应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00867 康哲药业
已收盘 04-19 16:08:35
7.000
-0.060
-0.85%
最高
7.070
最低
6.850
成交量
1,426万
今开
7.050
昨收
7.060
日振幅
3.12%
总市值
171.64亿
流通市值
171.64亿
总股本
24.52亿
成交额
9,941万
换手率
0.58%
流通股本
24.52亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
康哲药业(00867)出现大手成交330万股,成交价$6.935,涉资2.289千万
阿斯达克财经 · 13:00
康哲药业(00867)出现大手成交330万股,成交价$6.935,涉资2.289千万
康哲药业2023年营收净利双降12.4%和27.2%:面对国采政策影响的创新药布局与市场拓展
和讯网 · 04-18 21:01
康哲药业2023年营收净利双降12.4%和27.2%:面对国采政策影响的创新药布局与市场拓展
主力产品失速,营收、净利双双下滑,康哲药业如何重回正轨?
时代周报 · 04-18 17:19
主力产品失速,营收、净利双双下滑,康哲药业如何重回正轨?
康哲药业耗资742.38万港元回购106万股 股票回购增资行业分析
和讯网 · 04-18 04:00
康哲药业耗资742.38万港元回购106万股 股票回购增资行业分析
康哲药业(00867.HK)4月17日耗资742.38万港元回购106万股
格隆汇资讯 · 04-17 19:34
康哲药业(00867.HK)4月17日耗资742.38万港元回购106万股
康哲药业(00867)4月17日斥资742.38万港元回购106万股
智通财经 · 04-17 19:34
康哲药业(00867)4月17日斥资742.38万港元回购106万股
康哲药业04月17日主力资金流入904万元 连续7日加仓
自选股智能写手 · 04-17 16:15
康哲药业04月17日主力资金流入904万元 连续7日加仓
康哲药业(00867):磷酸芦可替尼乳膏中国澳门新药上市申请获批
智通财经 · 04-16
康哲药业(00867):磷酸芦可替尼乳膏中国澳门新药上市申请获批
康哲药业(00867)4月15日斥资744.4万港元回购105万股
智通财经 · 04-15
康哲药业(00867)4月15日斥资744.4万港元回购105万股
康哲药业(00867.HK)回购105万股 涉资约764.27万港元
财华社 · 04-15
康哲药业(00867.HK)回购105万股 涉资约764.27万港元
康哲药业4月11日斥资799.3万港元回购110万股
新浪港股 · 04-12
康哲药业4月11日斥资799.3万港元回购110万股
康哲药业(00867)4月11日斥资799.3万港元回购110万股
智通财经 · 04-11
康哲药业(00867)4月11日斥资799.3万港元回购110万股
康哲药业04月11日主力资金流入43万元 连续3日加仓
自选股智能写手 · 04-11
康哲药业04月11日主力资金流入43万元 连续3日加仓
康哲药业(00867)4月10日斥资767.04万港元回购103万股
智通财经 · 04-10
康哲药业(00867)4月10日斥资767.04万港元回购103万股
康哲药业04月10日获主力加仓929万元 环比增加1835.42%
自选股智能写手 · 04-10
康哲药业04月10日获主力加仓929万元 环比增加1835.42%
康哲药业4月9日斥资763.66万港元回购100万股
新浪港股 · 04-10
康哲药业4月9日斥资763.66万港元回购100万股
康哲药业(00867)4月9日斥资763.66万港元回购100万股
智通财经 · 04-09
康哲药业(00867)4月9日斥资763.66万港元回购100万股
《大行》高盛将润啤(00291.HK)及印度NTPC纳入亚太地区确信名单 剔除盐野义制药及康哲药业(00867.HK)
阿斯达克财经 · 04-09
《大行》高盛将润啤(00291.HK)及印度NTPC纳入亚太地区确信名单 剔除盐野义制药及康哲药业(00867.HK)
康哲药业4月8日耗资约1175.54万港元回购155万股
新浪港股 · 04-09
康哲药业4月8日耗资约1175.54万港元回购155万股
康哲药业(00867.HK)4月8日回购155.00万股 耗资1175.54万港元
证券时报网 · 04-08
康哲药业(00867.HK)4月8日回购155.00万股 耗资1175.54万港元
加载更多
公司概况
公司名称:
康哲药业
所属市场:
SEHK
上市日期:
--
主营业务:
康哲药业控股有限公司是一家主要从事医药产品的制造、推广、营销及销售业务的香港投资控股公司。其直接网络主要产品包括黛力新、优思弗、新活素、莎尔福、亿活及施图伦滴眼液等。其代理商推广网络产品包括沙多力卡、伊诺舒及喜达康等。其产品用于治疗胃病、心脏病、外伤感染、肝病及眼疾等。
发行价格:
--
{"stockData":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"康哲药业","latestPrice":7,"timestamp":1713514115027,"preClose":7.06,"halted":0,"volume":14261051,"delay":0,"floatShares":2451988512,"shares":2451988512,"eps":1.0583916,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.06,"latestTime":"04-19 16:08:35","open":7.05,"high":7.07,"low":6.85,"amount":99412644,"amplitude":0.031161,"askPrice":7.01,"askSize":148000,"bidPrice":7,"bidSize":152000,"shortable":3,"etf":0,"ttmEps":1.0583915798461516,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"adjPreClose":7.06,"dividendRate":0.060451,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":1.176273,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00867","defaultTab":"news","newsList":[{"id":"2428350238","title":"康哲药业(00867)出现大手成交330万股,成交价$6.935,涉资2.289千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2428350238","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428350238?lang=zh_cn&edition=full","pubTime":"2024-04-19 13:00","pubTimestamp":1713502800,"startTime":"0","endTime":"0","summary":"[大手成交]康哲药业(00867)在下午01:00出现大手成交,成交量为330万,成交价为港币$6.935,涉资2.289千万。至目前为止,股价跌1.7%,今日最高价为$7.05,而最低价为$6.85,总成交量为663.908万股,总成交金额港币$4.604千万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2404193057/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428591651","title":"康哲药业2023年营收净利双降12.4%和27.2%:面对国采政策影响的创新药布局与市场拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2428591651","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2428591651?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:01","pubTimestamp":1713445284,"startTime":"0","endTime":"0","summary":"\\u003cp\\u003e\\u003cbr\\u003e 康哲药业2023年年报显示,公司实现营收80.13亿元,同比下降12.4%;年度溢利23.84亿元,同比下降27.2%。这是公司自2010年上市以来首次出现营收和净利润双降。\\u003cbr\\u003e 康哲药业表示,集采影响将在2023年下半年和2024年上半年逐步消退,公司将依靠独家和创新药为主的产品结构,回归健康增长轨道。二级市场上,公司股价在2023年业绩公告后暴跌34.45%,之后持续疲软。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182133358b363af8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182133358b363af8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428550936","title":"主力产品失速,营收、净利双双下滑,康哲药业如何重回正轨?","url":"https://stock-news.laohu8.com/highlight/detail?id=2428550936","media":"时代周报","top":-1,"share":"https://www.laohu8.com/m/news/2428550936?lang=zh_cn&edition=full","pubTime":"2024-04-18 17:19","pubTimestamp":1713431946,"startTime":"0","endTime":"0","summary":"根据历年财报数据,这是2010年上市后,康哲药业首次出现营收、净利润双双下滑。届时,公司品种结构将以独家和创新药为主,更为健康的产品结构将支撑康哲药业重回持续健康增长轨道的起点。国采冲击主力业务受国采影响的三款产品分别为黛力新、波依定和优思弗,均是康哲药业在不同时期获得销售权益的代理产品。从各板块营收情况来看,心脑血管线和消化线占据康哲药业的营收大头。康哲药业方面表示。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181719318b35403b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181719318b35403b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428816303","title":"康哲药业耗资742.38万港元回购106万股 股票回购增资行业分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2428816303","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2428816303?lang=zh_cn&edition=full","pubTime":"2024-04-18 04:00","pubTimestamp":1713384045,"startTime":"0","endTime":"0","summary":"据康哲药业公告,该公司于2023年4月17日,通过港交所交易系统以总成交金额742.38万港元购回106万股股份,每股平均购回价格约为7.01港元。值得注意的是,康哲药业在2022年取得了较好的业绩,公司全年实现营业收入19.23亿元,同比增长8.3%;净利润达到9.49亿元,同比增长37.2%,增速远超行业平均。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418070202878c0029&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418070202878c0029&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428190303","title":"康哲药业(00867.HK)4月17日耗资742.38万港元回购106万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428190303","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2428190303?lang=zh_cn&edition=full","pubTime":"2024-04-17 19:34","pubTimestamp":1713353676,"startTime":"0","endTime":"0","summary":"格隆汇4月17日丨康哲药业(00867.HK)公告,4月17日耗资742.38万港元回购106万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041719344387891740&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041719344387891740&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428311937","title":"康哲药业(00867)4月17日斥资742.38万港元回购106万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428311937","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428311937?lang=zh_cn&edition=full","pubTime":"2024-04-17 19:34","pubTimestamp":1713353663,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康哲药业(00867)发布公告,该公司于2024年4月17日斥资742.38万港元回购106万股,回购价为每股6.95港元-7.04港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104064.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428239371","title":"康哲药业04月17日主力资金流入904万元 连续7日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428239371","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428239371?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:15","pubTimestamp":1713341710,"startTime":"0","endTime":"0","summary":"04月17日, 康哲药业股价跌1.12%,报收7.05元,成交金额9975万元,换手率0.58%,振幅6.17%,量比1.13。康哲药业今日主力资金净流入904万元,连续7日净流入,上一交易日主力净流入1155万元,今日环比减少21.73%。该股近5个交易日下跌4.19%,主力资金累计净流入3882万元;近20日主力资金累计净流入1281万元,其中净流入天数为11日。该股主力净额占比0.05%,港股市场排名85/2627。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171615208787fb44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171615208787fb44&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427787651","title":"康哲药业(00867):磷酸芦可替尼乳膏中国澳门新药上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2427787651","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427787651?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:43","pubTimestamp":1713278581,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康哲药业 发布公告,该公司欣然宣布,中华人民共和国澳门特别行政区政府药物监督管理局已于2024年4月11日批准磷酸芦可替尼乳膏(产品)新药上市申请,于2024年4月16日收到药品注册证书。产品用于治疗12岁及以上青少年和成人患者伴面部受累的非节段型白癜风。Incyte拥有磷酸芦可替尼乳膏全球开发和商业化权利,在美国及欧洲以Opzelura的名称销售。集团正有序推进芦可替尼乳膏在中国澳门的商业化工作,早日造福白癜风患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103612.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427676074","title":"康哲药业(00867)4月15日斥资744.4万港元回购105万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427676074","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427676074?lang=zh_cn&edition=full","pubTime":"2024-04-15 19:58","pubTimestamp":1713182280,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康哲药业(00867)发布公告,于2024年4月15日该公司斥资744.4万港元回购105万股股份,每股回购价格为7.04-7.16港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1102785.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427099032","title":"康哲药业(00867.HK)回购105万股 涉资约764.27万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427099032","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2427099032?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:25","pubTimestamp":1713144357,"startTime":"0","endTime":"0","summary":"【财华社讯】康哲药业(00867.HK)公布,于2024年04月12日回购105万股,每股回购价介乎7.21港元至7.35港元,涉资约764.27万港元。","market":"us","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/661c8226643dcf84e4ccd3fe","is_publish_highlight":false,"gpt_icon":0},{"id":"2426462210","title":"康哲药业4月11日斥资799.3万港元回购110万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426462210","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2426462210?lang=zh_cn&edition=full","pubTime":"2024-04-12 08:11","pubTimestamp":1712880682,"startTime":"0","endTime":"0","summary":"康哲药业(00867)发布公告,于2024年4月11日该公司斥资799.3万港元回购110万股,回购价格为每股7.16-7.34港元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarpmzf0609173.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarpmzf0609173.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426025512","title":"康哲药业(00867)4月11日斥资799.3万港元回购110万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426025512","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426025512?lang=zh_cn&edition=full","pubTime":"2024-04-11 19:54","pubTimestamp":1712836486,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康哲药业(00867)发布公告,于2024年4月11日该公司斥资799.3万港元回购110万股,回购价格为每股7.16-7.34港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101309.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426223865","title":"康哲药业04月11日主力资金流入43万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2426223865","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426223865?lang=zh_cn&edition=full","pubTime":"2024-04-11 16:15","pubTimestamp":1712823304,"startTime":"0","endTime":"0","summary":"04月11日, 康哲药业股价跌1.62%,报收7.28元,成交金额8357万元,换手率0.47%,振幅3.92%,量比0.77。康哲药业今日主力资金净流入43万元,连续3日净流入,上一交易日主力净流入929万元,今日环比减少95.37%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为72.73%,平均涨幅为1.85%。该股近5个交易日下跌2.93%,主力资金累计净流入912万元;近20日主力资金累计净流出1386万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111615178766786a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111615178766786a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426469222","title":"康哲药业(00867)4月10日斥资767.04万港元回购103万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426469222","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426469222?lang=zh_cn&edition=full","pubTime":"2024-04-10 19:06","pubTimestamp":1712747205,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康哲药业(00867)发布公告,该公司于2024年4月10日斥资767.04万港元回购103万股,回购价为每股7.36港元-7.56港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1100731.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426455768","title":"康哲药业04月10日获主力加仓929万元 环比增加1835.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426455768","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426455768?lang=zh_cn&edition=full","pubTime":"2024-04-10 16:15","pubTimestamp":1712736911,"startTime":"0","endTime":"0","summary":"04月10日, 康哲药业股价跌3.65%,报收7.40元,成交金额1.33亿元,换手率0.72%,振幅5.47%,量比0.89。康哲药业今日主力资金净流入929万元,上一交易日主力净流入48万元,今日环比增加1835.42%。该股近5个交易日下跌1.99%,主力资金累计净流入1239万元;近20日主力资金累计净流出1388万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101615248b0881a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101615248b0881a6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426177637","title":"康哲药业4月9日斥资763.66万港元回购100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426177637","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2426177637?lang=zh_cn&edition=full","pubTime":"2024-04-10 08:48","pubTimestamp":1712710117,"startTime":"0","endTime":"0","summary":"康哲药业(00867)发布公告,该公司于2024年4月9日斥资763.66万港元回购100万股,回购价为每股7.59港元-7.7港元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-10/doc-inarieau3255950.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-10/doc-inarieau3255950.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426166003","title":"康哲药业(00867)4月9日斥资763.66万港元回购100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426166003","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426166003?lang=zh_cn&edition=full","pubTime":"2024-04-09 18:36","pubTimestamp":1712658995,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康哲药业(00867)发布公告,该公司于2024年4月9日斥资763.66万港元回购100万股,回购价为每股7.59港元-7.7港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1100105.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426490739","title":"《大行》高盛将润啤(00291.HK)及印度NTPC纳入亚太地区确信名单 剔除盐野义制药及康哲药业(00867.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2426490739","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426490739?lang=zh_cn&edition=full","pubTime":"2024-04-09 10:03","pubTimestamp":1712628180,"startTime":"0","endTime":"0","summary":"高盛发表研究报告指,将华润啤酒(00291.HK) 及印度NTPC纳入亚太地区确信名单,并同时剔除盐野义制药及康哲药业(00867.HK) 。该行预期,润啤将在经营高端啤酒业务的同行中获得最大市场份额提升,并在2024至26年达到高端销售增长约11%,带动集团于期内销售额及净利润复合年增长率分别为5%和16%。至于NTPC,该行预计集团将受惠于中期内高峰电力短缺加剧引致的重新评级及可再生能源转型。(sl/cy)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-08 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112152951051_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112152951051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1340889/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2426903692","title":"康哲药业4月8日耗资约1175.54万港元回购155万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426903692","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2426903692?lang=zh_cn&edition=full","pubTime":"2024-04-09 09:07","pubTimestamp":1712624831,"startTime":"0","endTime":"0","summary":"康哲药业(00867)公布,2024年4月8日耗资约1175.54万港元回购155万股股份。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-09/doc-inareuwe2517947.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-09/doc-inareuwe2517947.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425857918","title":"康哲药业(00867.HK)4月8日回购155.00万股 耗资1175.54万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425857918","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2425857918?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:37","pubTimestamp":1712583433,"startTime":"0","endTime":"0","summary":"证券时报·数据宝统计,康哲药业在港交所公告显示,4月8日以每股7.530港元至7.630港元的价格回购155.00万股,回购金额达1175.54万港元。该股当日收盘价7.590港元,下跌0.13%,全天成交额1.10亿港元。今年以来该股累计进行3次回购,合计回购512.00万股,累计回购金额3841.60万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404083036510542.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404083036510542.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cms.net.cn","stockEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.4165},{"period":"3month","weight":-0.3976},{"period":"6month","weight":-0.3785},{"period":"1year","weight":-0.4486},{"period":"ytd","weight":-0.4899}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康哲药业控股有限公司是一家主要从事医药产品的制造、推广、营销及销售业务的香港投资控股公司。其直接网络主要产品包括黛力新、优思弗、新活素、莎尔福、亿活及施图伦滴眼液等。其代理商推广网络产品包括沙多力卡、伊诺舒及喜达康等。其产品用于治疗胃病、心脏病、外伤感染、肝病及眼疾等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.011253},{"month":2,"riseRate":0.538462,"avgChangeRate":0.023854},{"month":3,"riseRate":0.5,"avgChangeRate":0.004125},{"month":4,"riseRate":0.5,"avgChangeRate":0.022661},{"month":5,"riseRate":0.461538,"avgChangeRate":-0.005636},{"month":6,"riseRate":0.615385,"avgChangeRate":-0.002502},{"month":7,"riseRate":0.538462,"avgChangeRate":-0.016997},{"month":8,"riseRate":0.384615,"avgChangeRate":0.016149},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.018576},{"month":10,"riseRate":0.571429,"avgChangeRate":0.02168},{"month":11,"riseRate":0.571429,"avgChangeRate":0.06235},{"month":12,"riseRate":0.642857,"avgChangeRate":0.044014}],"exchange":"SEHK","name":"康哲药业","nameEN":"CMS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康哲药业,00867,康哲药业股票,康哲药业股票老虎,康哲药业股票老虎国际,康哲药业行情,康哲药业股票行情,康哲药业股价,康哲药业股市,康哲药业股票价格,康哲药业股票交易,康哲药业股票购买,康哲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}